Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Universe Pharmaceuticals Inc./ 20-F

SEC Filing · 20-F

Universe Pharmaceuticals Inc.

UPCNASDAQEQUITYCurrent

SEC Filing

Filed Apr 29, 2025Accepted Apr 29, 2025, 4:05 PM EDTCIK 1809616Accession 0001213900-25-036798
View company →Permanent SEC source ↗
Share

Company context

Current securities

UPCNASDAQ · EQUITY · Current

Recent company filings

  1. 6-K/A filingSep 3, 2026
  2. SCHEDULE 13G filingSep 1, 2026
  3. SCHEDULE 13G filingSep 1, 2026
  4. SCHEDULE 13G filingSep 1, 2026
  5. SCHEDULE 13G filingSep 1, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗